(HP-35) Poster Presentations

(HP-35) Poster Presentations


Poster Program

**This is a preliminary program and is subject to change**

Screening Technologies and Services

  • Angela HuangScientist and Founder, Tempo Bioscience – Using biosensors in human cell models – a new set of tools for drug discovery.
  • Chris Chambers – Scientist, Pfizer Neusentis – Compound Validation of NaV1.7 Assay using the Qube Automated Electrophysiology Platform.
  • Daniel Janssen – Scientist , Ablynx nv – Development of highly potent and selective Nanobodies® that operate through allosteric modulation.
  • Diane Van Hoorick – Senior Scientist, Ablynx nv – Nanobodies® against difficult targets: Tackling ion channels.
  • Juha Kammonen – Principal Scientist, Pfizer Neusentis – Utilizing fast determination of macroscopic ion channel time constants as a metric orthogonal to standard activity measurements in ion channel screening.
  • Yelena Bisharyan – Senior Research Scientist, Tetragenetics Inc. – SionX™ A Breakthrough Technology for Robust Expression and Purification of Correctly Folded and Functional Ion Channels.

Structure and Function of Ion Channels

  • Bonnie Wallace – Professor of Molecular Biophysics, University of London – Voltage-gated Sodium Channels: Structure and Function and Rational Drug Design.
  • Dieter Wicher – Group Leader Neurophysiology, Max Planck Institute for Chemical Ecology – Insect odorant receptors are regulated ion channels.
  • Waheed Shabbir – Professor, University of Vienna – Glycosylation-dependent lectin-receptor interaction stimulates inward sodium current in epithelial sodium channels.

Cardiac Safety and Pharmacology

  • Marc Pourrier – Vice President Operations, IonsGate Preclinical Services Inc. – Ranolazine Improves Diastolic Function in Spontaneously Hypertensive Rats.
  • Ferninda Gaisler da Silva -Graduate Student, University of Ottawa– CaMKII beta isoform induced dilation, hypertrophy and heart failure in mice.
  • Mayra Sonoda – Graduate Student, University of Ottawa The Sarcolemmal Membrane Associated Protein (SLMAP) impacts cardiac contractile and electrical properties.